Calcium channel blockers and modulation of innate immunity
1Peking University People's Hospital, Beijing, China.
Insights
Calcium channel blockers (CCBs) are increasingly recognized for their role in modulating innate immunity. Recent findings suggest these cardiovascular drugs may also suppress immune cell activation, offering potential new therapeutic avenues.
Area of Science:
- Immunology
- Cardiology
- Pharmacology
Background:
- Pro-inflammatory cytokines can cause tissue injury and cardiac decompensation.
- Modulating innate immune responses in the heart is a key clinical challenge.
- Calcium channel blockers (CCBs) are widely used for cardiovascular disorders.
Purpose of the Study:
- To review recent research on the utility of CCBs in modulating innate immunity.
- To explore the immunosuppressive potential of CCBs beyond their cardiovascular effects.
Main Methods:
- Literature review of in-vitro studies on CCBs and immune cell activation.
- Analysis of CCB mechanisms of action on cardiac and immune cells.
Main Results:
- CCBs, including nifedipine, amlodipine, diltiazem, and verapamil, inhibit calcium influx and release.
- In-vitro studies indicate CCBs suppress the activation of T cells, mast cells, and macrophages.
- These findings suggest a potential immunosuppressive role for CCBs.
Conclusions:
- CCBs may possess immunosuppressive properties by suppressing immune cell activation.
- Further research is needed to fully understand and utilize the immunomodulatory effects of CCBs in clinical practice.
Purpose Of Review:
Researchers and physicians are gaining more understanding of the utility of calcium channel blockers (CCBs) especially in modulation of innate immunity, and choose suitable ones in clinical practice. This review summarizes the recent related research findings.
Recent Findings:
Sustained and/or dysregulated expression of pro-inflammatory cytokines is sufficient to produce tissue injury and provoke overt cardiac decompensation. The important question that remains to be addressed is whether or not it will be possible to modulate the inappropriate or maladaptive consequences of innate immune activation and pro-inflammatory cytokine expression in the mammalian heart. CCBs, such as nifedipine, amlodipine, diltiazem, and verapamil, promote the relaxation of cardiac and smooth muscle cells by inhibiting calcium influx through calcium channels and calcium release from intracellular stores, and are commonly used in the treatment of cardiovascular disorders. Recently, several in-vitro studies have shown that, besides the effects they exert on muscle cells, CCBs also suppress the activation of various participants in immune reactions, including T cells, mast cells and macrophages, suggesting that they can be immunosuppressant.
Summary:
CCBs maybe suppress the activation of various participants in immune reactions.
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
01:16Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...